baber/WOPTO huggingface dataset:
Patent AU-2010310816-A1 (AU)
Title: Methods for characterization of formations, navigating drill paths, and placing wells in earth boreholes
Inventor: SEYDOUX JEAN
IPC: E21B47/02
Filed: 2010-10-15
Abstract: A method for directing borehole drilling in a target earth formation includes the following steps: providing drilling equipment having a bottom hole assembly that includes a controllable directional drilling subsystem, and a logging-while- drilling directional measurement tool with a look-around and look-ahead capability; determining the presence of a predetermined type of formation characteristic in the target formation; and navigating a drill path in the target formation with the drilling equipment, including receiving measurement signals from the directional measurement tool, obtaining, from the received measurement signals, indications of formation parameters with respect to the formation characteristic in the target formation, and controlling the directional drilling subsystem to drill in a direction determined as a function of the obtained indication of formation parameters.
Patent AU-2010315420-A1 (AU)
Title: Plastic container with improved sidewall configuration
Inventor: GILL MATTHEW T
IPC: B65D1/02
Filed: 2010-10-28
Abstract: A plastic container (10) that is adapted for adjustment to internal volumetric changes such as those that occur during the hot- fill process includes a container body (12) defining an internal space and having a sidewall (14). The container body has a maximum lateral dimension and a plurality of flexible panels and posts (24) defined in the sidewall. The posts (24) are respectively interposed between the flexible panels (22) around the outer circumference of the sidewall. Each of the plurality of posts (24) has a minimum width and a maximum width, and a ratio of the minimum width to maximum width is preferably within a range of about 0.3 to about 0.7. A ratio of the minimum width to the maximum lateral dimension is preferably within a range of about 0.05 to about 0.30. In addition, a ratio of the maximum width to the maximum lateral dimension is preferably within a range of about 0.15 to about 0.45.
Patent AU-2010329332-A1 (AU)
Title: Azole derivatives, methods for producing the same, intermediate thereof, agro-horticultural agents
Inventor: ARAKI NOBUYUKI
IPC: C07D405/06
Filed: 2010-12-07
Abstract: An azole derivative according to the invention is represented by Formula (I), wherein each of R and R denotes a hydrogen atom, or a C-C alkyl group, a C-C alkenyl group or a C-C alkynyl group; R and R may be substituted with X or X which is a halogen atom; each of n and n denotes 0 or the number of X- or X-substituted hydrogen atoms among the hydrogen atoms in Ror R; each Y denotes a halogen atom, a C-C alkyl group, a C-C haloalkyl group, a C-C alkoxy group, a C-C haloalkoxy group, a phenyl group, a cyano group or a nitro group; m denotes 0 to 5; and A denotes a nitrogen atom or a methyne group. As a result, an azole derivative contained as an active ingredient in an agro-horticultural agent having an excellent controlling effect on diseases can be provided.
Patent AU-2010344006-A1 (AU)
Title: Portable EEG monitor system with wireless communication
Inventor: KIDMOSE PREBEN
IPC: G16H40/67
Filed: 2010-02-01
Abstract: A system for remote surveillance of an EEG signal of a person susceptible of having a hypoglycemic seizure, comprising an EEG sensor part (2) with electrodes (5) for measuring one or more EEG signals from the person, and comprising a processing unit (4) adapted to be removable arranged at the ear of said person, having EEG signal processing means (13) for analyzing the EEG signal, where the signal processing means are adapted for, based on the EEG signal, identifying or predicting a hypoglycemic seizure in the person. The processing part (4) comprises decision means for deciding, based on said analyzed EEG signal, when an alarm or information must be provided. The system comprise a first connection (12) between the EEG sensor part (2) and the processing unit (4), adapted for transmitting an EEG signal from the implantable EEG sensor to the processing unit. The system comprise an external part (3) adapted to receive wirelessly an alarm from the processing part, where the external part is adapted to forward an alarm to a care giver. The system comprise a second connection (20) between the processing unit and the external part, this second connection is wireless.
Patent WO-2012048369-A1 (WO)
Title: Ensemble soupape
Inventor: WILSON IAN FRANCIS
IPC: F16K24/04
Filed: 2011-10-11
Abstract: La présente invention concerne un ensemble soupape permettant le contrôle de l'écoulement d'un fluide, l'ensemble soupape comportant un corps principal avec un orifice d'entrée et un orifice de sortie, le corps principal comprenant: un chemin primaire d'écoulement de fluide depuis l'orifice d'entrée jusqu'à l'orifice de sortie, le chemin d'écoulement primaire étant apte à être fermé par un premier organe de soupape ; et, un chemin secondaire d'écoulement de fluide fournissant un chemin alternatif de fluide depuis l'orifice d'entrée jusqu'à l'orifice de sortie, le chemin d'écoulement secondaire de fluide étant apte à être fermé par un second organe de soupape, la différence de pression entre le fluide à l'orifice d'entrée et le fluide à l'orifice de sortie entraînant l'ouverture du second organe de soupape pour permettre l'écoulement du fluide via le chemin secondaire d'écoulement de fluide.
Patent AU-2011201360-A1 (AU)
Title: Systems and methods for creating a form for receiving data relating to a health care incident
Inventor: JIAN ZHOU
IPC: G06F40/00
Filed: 2011-03-24
Abstract: Title: Systems and Methods for Creating a Form for Receiving Data Relating to a Health Care Incident Abstract 5 Embodiments of the invention relate to systems and methods for creating a form for receiving data relating to a health care incident. A dictionary of field objects is provided in a metabase, where a field object defines attributes, and an instance of a field object is a form field. A request to create a user-defined field object is received and it is determined that the user-defined field object is not in the dictionary of field objects 10 in the metabase. The user-defined field object is generated by defining attributes for the user-defined field object, where at least one attribute is a presentation attribute for a form field within a form. The user-defined field object is added to the dictionary of field objects in the metabase and the user-defined field object is linked to a data location in a persistent store. The form is generated, where the form is an ordered collection of form 15 fields, where at least one form field is an instance of the user-defined field object and is displayed according to the at least one presentation attribute. l ElY 1cc Kw z6
Patent AU-2011202495-A1 (AU)
Title: Window system
Inventor: SCOTT SPENCER MICHAEL
IPC: E06B3/66
Filed: 2011-05-27
Abstract: Abstract A structural frame member for use in a double-glazed window system, the structural frame member including a first frame portion and a second frame portion, each frame portion having an inner and outer longitudinal frame element separated by at least one thermally isolating strip; and 5 at least two connectors coupling the first frame portion to the second frame portion. Each frame element has a first formation and the connector has second formations corresponding to the first formations to couple the frame portions together. 2o 24 Figure 1 Figure 2
Patent AU-2011203365-A1 (AU)
Title: Expandable processing and expression chamber
Inventor: KEITH ROSIELLO
IPC: B04B5/04
Filed: 2011-07-07
Abstract: A flexible centrifuge chamber comprising a substantially flexible first side and a 5 substantially flexible second side and having an expandable wall, wherein a first end of the expandable wall is attached to a circumference of the first side of the flexible chamber and a second end of the expandable wall is attached to a circumference of the second side of the flexible chamber, wherein the expandable wall comprises an accordion wall having substantially no rigid portions; and wherein the chamber is 10 sterilized. (Figure 1) 145 COMPARTMEN 14 64U O CHAMBER S Cr~OPTICAL FLUID MANAGEMENT CASSETTES SECENTRSFUGE
Patent AU-2011223895-A1 (AU)
Title: Fluorouracil derivatives
Inventor: PERSICHETTI ROSE A
IPC: A01N43/04
Filed: 2011-02-28
Abstract: This invention relates to novel fluorouracil derivatives of Formula I or pharmaceutically acceptable salts thereof. This invention also provides compositions comprising a compound of this invention and the use of such compositions in methods of treating diseases and conditions that are beneficially treated by administering a thymidylate synthase inhibitor.
Patent AU-2011245303-A1 (AU)
Title: Surgical drape kit
Inventor: MCCOLLOUGH ANDRYE
IPC: A61B46/23
Filed: 2011-04-28
Abstract: A surgical drape kit for performing a surgical procedure includes a surgical drape having a fenestration site; a plurality of containers attached to the surgical drape; and a plurality of components used to perform a surgical procedure. The containers are attached to the surgical drape around a perimeter of the fenestration site. Each container includes at least one component. Disposition of the components inside the containers is determined by sequential steps of the surgical procedure.
Patent AU-2011250884-A1 (AU)
Title: Therapeutic liposomes and methods for producing and using the same
Inventor: SCHMIDT MICHAEL A
IPC: A61K9/127
Filed: 2011-05-10
Abstract: The present invention provides therapeutic liposomes and methods for producing and using the same. In particular, therapeutic liposomes of the invention comprise phospholipids comprising C-C fatty acid ester moieties. In some embodiments, these therapeutic liposomes are used in assisting delivery of an active compound, e.g., a drug and/or a nutraceutical, to a subject. In some embodiments, compositions of the invention have synergistic therapeutic effect.
Patent AU-2011253844-A1 (AU)
Title: Compositions containing, methods involving, and uses of non-natural amino acids and polypeptides
Inventor: ZHENWEI MIAO
IPC: A61K38/00
Filed: 2011-12-05
Abstract: Disclosed herein are non-natural amino acids and polypeptides that include at least one non-natural amino acid, and methods for making such non-natural amino acids and polypeptides. The non-natural amino acids, by themselves or as a part of a polypeptide, can include a wide range of possible functionalities, but typical have at least one aromatic amine group. Also disclosed herein are non-natural amino acid polypeptides that are further modified post-translationally, methods for effecting such modifications, and methods for purifying such polypeptides. Typically, the modified non natural amino acid polypeptides include at least one alkylated amine group. Further disclosed are methods for using such non-natural amino acid polypeptides and modified non-natural amino acid polypeptides, including therapeutic, diagnostic, and other biotechnology uses.
Patent AU-2011261669-A1 (AU)
Title: Magnetically coupled implantable pump system
Inventor: AUGARTEN MIKE
IPC: A61F5/00
Filed: 2011-05-27
Abstract: A magnetically coupled, implantable pump system comprises an external controller and an implantable device. A non-implantable magnet in an external controller produces a magnetic field that couples the non-implantable magnet to a magnet in the implantable device. A non-implantable motor moves the non-implantable magnet in a rotational direction. When the non-implantable magnet moves in the rotational direction, a piston coupled to the magnet moves within the implantable device. As the piston moves, an amount of fluid from a reservoir in the implantable device moves out of the reservoir and into an inflatable portion of a gastric band. The implantable device may also move fluid out of the inflatable portion of the gastric band.
Patent AU-2011263786-A1 (AU)
Title: Tear lipocalin muteins binding IL-4 r alpha
Inventor: HOHLBAUM ANDREAS
IPC: A61K39/00
Filed: 2011-06-08
Abstract: The present invention relates to novel muteins derived from human tear lipocalin, which bind to IL 4 receptor alpha. The sequences of the muteins comprise particular combinations of amino acids. In particular a mutated amino acid residue is present at any one or more of the sequence positions 27, 28, 30, 31, 33, 53, 57, 61, 64, 66, 80, 83, 104-106 and 108 of the linear polypeptide sequence of the mature human tear lipocalin. A mutated amino acid residue is also present at any 2 or more of the sequence positions 26, 32, 34, 55, 56, 58 and 63 of the linear polypeptide sequence of the mature human tear lipocalin. The invention also provides a corresponding nucleic acid molecule encoding such a mutein and a method for producing such a mutein and its encoding nucleic acid molecule.
Patent AU-2011286430-A1 (AU)
Title: User targeted medical imaging and information packaging compression and distribution system
Inventor: PACE CHARLES P
IPC: G16H10/60
Filed: 2011-05-23
Abstract: A computer-based method and system of distributing biological sample data acquires a digital image of a subject biological sample. The acquired digital image and image capture data are processed according to at least one user. This results in processed image data and capture metadata. The processed image data represents biological sample data of the subject biological sample. A package processing combines the processed image data and capture metadata into a working Package. The method and system enables simultaneous electronic access to the working Package by multiple users, across multiple sectors, in addition to the one user.
Patent AU-2011292160-A1 (AU)
Title: Ophthalmic formulations of squalamine
Inventor: TARAPOREWALA IRACH B
IPC: A61K9/00
Filed: 2011-08-16
Abstract: The invention relates to ophthalmic formulations of squalamine or its pharmaceutically acceptable salts for the treatment of conditions of the eye such as, for example, wet age-related macular degeneration (wet AMD), choroidal neovascularization, retinopathy, dry age-related macular degeneration (dry AMD), polypoidal choroidal vasculopathy, neovascularization following ocular surgery, macular edema, retinal venous occlusion, subchoroidal neovascularization, retinal epithelial detachment, pterygum or foveal geographic atrophy of the retinal pigment epithelium.
Patent AU-2011292220-A1 (AU)
Title: Field deployable concussion assessment device
Inventor: PRICHEP LESLIE S
IPC: A61B5/0476
Filed: 2011-08-12
Abstract: A device and method for assessment of traumatic brain injury (TBI) is described. The device is configured to acquire brain electrical signals from a patient's forehead using one or more neurological electrodes. The acquired brain electrical activity data is subjected to artifact rejection and feature extraction, and a subset of features are then combined in at least one classifier function. The classifier functions statistically place a patient in one of four categories related to the extent of brain dysfunction: 1) normal brain electrical activity; 2) abnormal brain electrical activity consistent with non-structural injury with less severe manifestations of functional brain injury; 3) abnormal brain electrical activity consistent with non-structural injury with more severe manifestations of functional brain injury; and 4) abnormal brain electrical activity consistent with structural brain injury.
Patent AU-2011319978-A1 (AU)
Title: Star macromolecules for personal and home care
Inventor: JAKUBOWSKI WOJCIECH
IPC: C09K23/52
Filed: 2011-10-26
Abstract: A polymer composition comprising star macromolecules is provided. Each star macromolecule has a core and five or more arms, wherein the number of arms within a star macromolecule varies across the composition of star molecules. The arms on a star are covalently attached to the core of the star; each arm comprises one or more (co)polymer segments; and at least one arm and/or at least one segment exhibits a different solubility from at least one other arm or one other segment, respectively, in a reference liquid of interest.
Patent AU-2011320635-A1 (AU)
Title: Therapeutic solution concentrate
Inventor: REO JOSEPH P
IPC: B01F23/00
Filed: 2011-10-24
Abstract: A concentrated poly(ethylene glycol) solution that has good stability for extended storage is provided for use as a laxative. The concentrated solution comprises water, sodium benzoate, poly(ethylene glycol), and enough acid to yield a solution having a pH at 25 C in the range 3.0-5.0. It is prepared and packaged to minimize the accumulation of degradation products.
Patent AU-2011333417-A1 (AU)
Title: A non-return valve for a tubular consolidation element
Inventor: BONOMI CRISTIANO
IPC: F16K15/14
Filed: 2011-08-30
Abstract: A non- return valve can be fitted on a tubular element for use for the reinforcement and consolidation of a soil, for example, in an excavation. The non -return valve may comprise a portion made of elastomer material which has a least one nick (41,42,43,44,150) and is connected to a structural body (2,102) preferably made of metal, that can be tightened onto the tubular element (3, 103).
Patent WO-2013040648-A1 (WO)
Title: Immunogène glpo pneumococcique
Inventor: PATON JAMES
IPC: A61K38/44
Filed: 2012-09-21
Abstract: L'invention concerne une composition immunogène qui peut être un vaccin comprenant GlpO ou un fragment de celui-ci, approprié pour l'utilisation dans le traitement ou la prévention d'une infection streptococcique, en particulier une méningite. Le GlpO ou le fragment de celui-ci est de préférence inactif du point de vue enzymatique. Dans une forme préférée, la composition immunogène comprend en outre un immunogène supplémentaire connu comme étant protecteur contre une infection streptococcique, ledit immunogène supplémentaire étant de préférence une protéine. Une telle protéine supplémentaire particulièrement illustrée est une pneumolysine non toxique.
Patent AU-2012205208-A1 (AU)
Title: Nicotinic acetylcholine receptor sub-type selective amides of diazabicycloalkanes
Inventor: MAZUROV ANATOLY
IPC: C07D487/04
Filed: 2012-07-18
Abstract: SUB-TYPE SELECTIVE AMIDES OF DIAZABICYCLOALKANES Abstract Compounds, pharmaceutical compositions including the compounds, and methods of preparation and use thereof are disclosed. The compounds are amide compounds which can be prepared from certain heteroaryl carboxylic acids and certain diazabicycloalkanes. The compounds exhibit selectivity for, and bind with high affinity to, neuronal nicotinic receptors of the c42 subtype in the central nervous system (CNS). The compounds and compositions can be used to treat and/or prevent a wide variety of conditions or disorders, particularly CNS disorders. The compounds can: (i) alter the number of nicotinic cholinergic receptors of the brain of the patient, (ii) exhibit neuroprotective effects, and (iii) when employed in effective amounts, not result in appreciable adverse side effects (e.g. side effects such as significant increases in blood pressure and heart rate, significant negative effects upon the gastrointestinal tract, and significant effects upon skeletal muscle).
Patent AU-2012222463-A1 (AU)
Title: Cea antibodies
Inventor: HOFER THOMAS U
IPC: C07K16/30
Filed: 2012-02-29
Abstract: The present invention provides antigen binding molecules (ABMs) which bind membrane-bound CEA, including ABMs with improved therapeutic properties, and methods of using the same.
Patent AU-2012245501-A1 (AU)
Title: System and method for automatically addressing devices in a multi-drop network
Inventor: SPITAELS JAMES S
IPC: H04L29/12
Filed: 2012-04-18
Abstract: Systems and methods that automatically assign addresses to devices coupled to a shared bus are provided. In one example, a system for assigning addresses to a plurality of devices within a network includes a memory and at least one processor coupled to the memory. The system is configured to instruct all of the plurality of devices to respectively select a first dynamic address from a first set of dynamic addresses, respectively assign a different static address to each device having a first dynamic address that uniquely identifies the device, instruct all of the plurality of devices having a first dynamic address that identifies at least two devices to respectively select a second dynamic address from a second set of dynamic addresses and respectively assign another different static address to each device having a second dynamic address that uniquely identifies the device.
Patent AU-2012247091-A1 (AU)
Title: Pallet-Dolly
Inventor: SADEH DAGAN
IPC: B62B3/00
Filed: 2012-11-14
Abstract: A pallet-dolly device convertible between a pallet and a dolly has a generally rectangular deck to which a set of dolly wheels are attached at a fixed height below the deck. A set of movable pallet skids are moved by a skid displacement mechanism between a skid lowered position in which a ground contacting surface of the skid is lowered below a contact plane of the wheels to provide a pallet state of the pallet-dolly device, and a skid raised position in which the skid ground contacting surface is raised above the wheel contact plane to provide a dolly state of the pallet dolly device. At least two pedals, accessible from two adjacent sides of the deck, are deployed to be operated by a user to activate the skid displacement mechanism. Pl19aY/
Patent AU-2012250862-A1 (AU)
Title: Rapid dissolve tablet compositions for vaginal administration
Inventor: VENKATESH GOPI
IPC: A61K9/16
Filed: 2012-05-02
Abstract: Disclosed herein are pharmaceutically acceptable rapid dissolve vaginal tablet compositions comprising one or more active pharmaceutical ingredients suitable for therapy via topical action or systemic absorption, and methods of making and using such compositions. In some embodiments, this invention relates to pharmaceutical compositions comprising one or more active pharmaceutical ingredients suitable for vaginal route of administration, and methods of making and using such compositions for therapy via topical action or systemic absorption, as well as uterine targeting. In certain embodiments, the present invention is related to a pharmaceutical composition comprising one or more active pharmaceutical ingredients suitable for vaginal route of administration, one or more polymeric excipients having a dual property of acting as a binder as well as a bioadhesive material, one or more sugar alcohols or saccharides, and one or more disintegrants.
Patent AU-2012257467-A1 (AU)
Title: Process for treating cellulose and cellulose treated according to the process
Inventor: HEISKANEN ISTO
IPC: B01D61/56
Filed: 2012-05-11
Abstract: The present invention relates to a process for purifying a slurry comprising cellulose, such as microfibrillated cellulose, wherein the process comprises the following steps: - providing a slurry comprising cellulose and liquid, - subjecting the slurry to an electric field inducing the liquid of the slurry to flow, - separating the liquid from the cellulose thus obtaining a liquid depleted slurry, - adding a washing liquid, such as an organic solvent, to the liquid depleted slurry - subjecting the liquid depleted slurry to an electric field inducing the washing liquid of the slurry to flow and - separating the washing liquid from the cellulose, thus obtaining a purified cellulose. The invention also relates to cellulose such as microfibrillated cellulose obtainable from said process.